Update: Slower H1, better momentum H2
Creston’s interim results outline a busy period of acquisitions, start-ups, investments and partnerships, which are showing through in a strong new business performance, with some high-profile names added to the client roster. This is tempered by the twin impacts of currency movements and the slower start to the year – previously signalled – but of a larger quantum than expected in the health sector. Underperformance of the share price has left the valuation at a discount to peers, which should correct once profits and earnings are more robustly moving in the right direction.
Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.
.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.